4.8 Article

MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer

Journal

IMMUNITY
Volume 38, Issue 4, Pages 742-753

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2012.12.006

Keywords

-

Categories

Funding

  1. MEDIC Foundation
  2. New Zealand Foundation for Research, Science and Technology
  3. Swiss National Science Foundation (SNSF)
  4. US NIH National Cancer Institute, Center for Cancer Research
  5. NIH National Institute of Allergy and Infectious Diseases

Ask authors/readers for more resources

MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) T cell immunity remains unknown. Here we report that miRNA-155 is required for CD8(+) T cell responses to both virus and cancer. In the absence of miRNA-155, accumulation of effector CD8(+) T cells was severely reduced during acute and chronic viral infections and control of virus replication was impaired. Similarly, Mir155(-/-) CD8(+) T cells were ineffective at controlling tumor growth, whereas miRNA-155 overexpression enhanced the antitumor response. miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5. Consistently, enforced expression of SOCS-1 in CD8(+) T cells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction. These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8(+) T cells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available